Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 3 November 2000:
Vol. 290. no. 5493, pp. 923 - 925
DOI: 10.1126/science.290.5493.923
Prev | Table of Contents | Next

News Focus

EMERGING DISEASES:
On the Trail of Ebola and Marburg Viruses

Michael Balter

MARBURG, GERMANY--Last month, about 100 Marburg and Ebola virus experts met here to share their latest results. Although many questions remain, the new research raised hopes that treatments and vaccines might one day be a reality. The findings included the creation of a genetically engineered Ebola virus, which should provide a powerful molecular tool to analyze how these viruses cause disease, and promising, though preliminary, results in monkeys with an Ebola vaccine.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Ebola Virus Glycoproteins Induce Global Surface Protein Down-Modulation and Loss of Cell Adherence.
G. Simmons, R. J. Wool-Lewis, F. Baribaud, R. C. Netter, and P. Bates (2002)
J. Virol. 76, 2518-2528
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)